SCHEMBL3135964

SCHEMBL3135964

O=C(O)Cc1ccccc1OC[C@H](O)CNC1CCN(Cc2ccc(F)c(F)c2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.57
SIGMAR1 Q99720 7/20 0.54
LMNA P02545 2/20 0.52
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
KDM4E B2RXH2 2/20 0.49
MITF O75030 1/20 0.49
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ADRB2 P07550 2/20 0.48
ADRB1 P08588 2/20 0.48
ADRB3 P13945 2/20 0.48
CCR3 P51677 3/20 0.46
HRH1 P35367 2/20 0.46
GMNN O75496 1/20 0.45
PMP22 Q01453 1/20 0.45
BCHE P06276 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3135950 1.00 ABCB11 (0.57) ABCB11SIGMAR1LMNAKMT2AMEN1
Trifluoroacetic Acid SCHEMBL3150058 0.96 ABCB11 (0.53) ABCB11SIGMAR1LMNAKMT2AMEN1
SCHEMBL3135915 0.93 ABCB11 (0.59) ABCB11SIGMAR1LMNAKMT2AMEN1
SCHEMBL3135904 0.93 ABCB11 (0.59) ABCB11SIGMAR1LMNAKMT2AMEN1
SCHEMBL3150600 0.91 ABCB11 (0.60) ABCB11SIGMAR1LMNAKMT2AMEN1
SCHEMBL3150611 0.91 ABCB11 (0.60) ABCB11SIGMAR1LMNAKMT2AMEN1
Trifluoroacetic Acid SCHEMBL3145623 0.89 ABCB11 (0.55) ABCB11SIGMAR1LMNAKMT2AMEN1
Trifluoroacetic Acid SCHEMBL3145788 0.87 ABCB11 (0.56) ABCB11SIGMAR1LMNAKMT2AMEN1
SCHEMBL3150449 0.87 ABCB11 (0.59) ABCB11SIGMAR1LMNAKMT2AMEN1
SCHEMBL3150457 0.87 ABCB11 (0.59) ABCB11SIGMAR1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081692-A1 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma ASTRAZENECA AB (SE) 2010-04-01 US claimed
EP-1945613-A1 NOVEL 1 -BENZYL-4-PIPERIDINAMINES THAT ARE USEFUL IN THE TREATMENT OF COPD AND ASTHMA AstraZeneca AB (SE) 2008-07-23 EP claimed
WO-2007053082-A1 NOVEL 1 -BENZYL-4-PIPERIDINAMINES THAT ARE USEFUL IN THE TREATMENT OF COPD AND ASTHMA ASTRAZENECA AB (SE) 2007-05-10 WO claimed
US-20100081692-A1 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma ASTRAZENECA AB (SE) 2010-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081692-A1 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma CCR1, CCR4, CCR10 ABCB11 477/4885SIGMAR1 1722/4885LMNA 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.